Investments in Other Entities (Tables)

6 Months Ended

Jun. 30, 2022

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments

Investments in other entities – equity method consisted of the following (in thousands):

	December 31, 2021		Allocation of Income (Loss)		Funding reclassified to loan receivable		Funding		Distribution		June 30, 2022
LaSalle Medical Associates – IPA Line of Business	$	3,034	$	2,535	$	(2,125)	$	—	$	—	$	3,444
Pacific Medical Imaging & Oncology Center, Inc.	1,719		22		—		—		—		1,741
531 W. College, LLC – related party	17,230		(305)		—		250		—		17,175
One MSO, LLC – related party	2,910		254		—		—		(400)		2,764
Tag-6 Medical Investment Group, LLC – related party	4,830		111		—		1,435		—		6,376
CAIPA MSO, LLC	11,992		328		—		—		—		12,320
	$	41,715	$	2,945	$	(2,125)	$	1,685	$	(400)	$	43,820

LMA’s summarized balance sheets at June 30, 2022 and December 31, 2021, and summarized statements of income for the six months ended June 30, 2022 and 2021, with respect to its IPA line of business are as follows (in thousands):

Balance Sheets

	June 30, 2022		December 31, 2021
	(unaudited)		(unaudited)
Assets
Cash and cash equivalents	$	16,250	$	6,619
Restricted cash	698		696
Receivables, net	5,516		2,269
Loan receivable	2,250		2,250
Total assets	$	24,714	$	11,834
Liabilities and Stockholders’ Deficit
Current liabilities	$	35,266	$	32,405
Stockholders’ deficit	(10,552)		(20,571)
Total liabilities and stockholders’ deficit	$	24,714	$	11,834

Statements of Operations

	Six Months Ended June 30,
	2022		2021
	(unaudited)		(unaudited)
Revenues	$	126,067	$	95,212
Expenses	121,406		104,570
Income (loss) from operations	4,661		(9,358)
Other loss	(58)		—
Net income (loss)	$	4,603	$	(9,358)